NYRADA INC.

8.23%

72.5¢

Market Cap $0

Healthcare Biotechnology

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Recce Pharmaceuticals (ASX:RCE) Commences Phase 3 Indonesian Trial with First Patient Dosed

Latest Threads

Tag

Subject

NYR

PART 2 - USA Peer Analysis

22:23

7.4K

22:23

Last post Noid

7.4K

NYR

PART 1 - NYR Aus Peer Analysis

4 5 6

18:39

350

45K

18:39

Last post Bendunstan

350

45K

NYR

Ann: Nyrada Half Year Results FY2025

2 3

15/12/25

162

43K

15/12/25

Last post Bendunstan

162

43K

NYR

Ann: Nyrada Quarterly Activities Report & Appendix 4C

13/12/25

14K

13/12/25

Last post 0man

14K

NYR

Ann: Significant Neuroprotection in Traumatic Brain Injury Study

13/12/25

9.0K

13/12/25

Last post 0man

9.0K

NYR

CHART

8 9 10

12/12/25

542

94K

12/12/25

Last post Bendunstan

542

94K

NYR

Ann: Change of Director's Interest Notice - JM

11/12/25

3.5K

11/12/25

Last post Bendunstan

3.5K

NYR

Ann: Change of Director's Interest Notice - CC

11/12/25

1.8K

11/12/25

Last post Bendunstan

1.8K

See All Discussions

Timeline

Change of Director's Interest Notice - JM
10 Dec 09:53	Share

Change of Director's Interest Notice - MF
10 Dec 09:53	Share

Change of Director's Interest Notice - RW
10 Dec 09:53	Share

Change of Director's Interest Notice - CC
10 Dec 09:52	Share

Cleansing Statement
10 Dec 09:45	Share

Application for quotation of securities - NYR
10 Dec 09:44	Share

Change of Director's Interest Notice - JM
05 Dec 18:33	Share

Change of Director's Interest Notice - MF
05 Dec 18:33	Share

Change of Director's Interest Notice - RW
05 Dec 18:33	Share

Cleansing Statement
05 Dec 18:29	Share

Application for quotation of securities - NYR
05 Dec 18:28	Share

Investor Presentation
26 Nov 08:26	Share

Capital Structure
25 Nov 09:51	Share

Cleansing Statement
24 Nov 16:08	Share

Application for quotation of securities - NYR
24 Nov 16:06	Share

Becoming a substantial holder - Matt Corp WA PL
24 Nov 08:38	Share

Nyrada Phase IIa Clinical Trial Update
18 Nov 10:54	Share

Cleansing Statement
13 Nov 11:37	Share

Application for quotation of securities - NYR
13 Nov 11:35	Share

Final Director's Interest Notice
12 Nov 16:58	Share

Change of Director's Interest Notice
12 Nov 16:53	Share

Notification of cessation of securities - NYR
12 Nov 16:19	Share

Results of Meeting
12 Nov 12:41	Share

AGM Chair Address
12 Nov 08:23	Share

AGM Presentation
12 Nov 08:23	Share

Investor Presentation and CEO AGM Presentation
10 Nov 08:26	Share

Upcoming Release of Securities from Voluntary Escrow
07 Nov 16:44	Share

Cleansing Statement
05 Nov 16:55	Share

Application for quotation of securities - NYR
05 Nov 16:53	Share

Cleansing Statement
03 Nov 16:18	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 72.5¢		Change -0.065(8.23%)		Mkt cap ! N/A

Open	High	Low	Volume
82.0¢	82.0¢	69.5¢	865.9K

Buyers (Bids)

Vol.	Price($)
2500	71.5¢

Sellers (Offers)

Price($)	Vol.
73.0¢	910

Last trade - 16.10pm 17/12/2025 (20 minute delay)

NYR (ASX) Chart

NYRADA INC.

Latest Threads

An hour ago silver hit a new all time high... here are the 8 ASX silver stocks we are invested in.

Timeline

Featured News

Latest Articles

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical trial into its drug for neuroprotection and cardioprotection

Study finds Nyrada's lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to assess the safety and tolerability of NYR-BI03

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News